Who owns Rapport Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of RAPP from SEC Form 13F filings across 169 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 169 institutions disclosed 50.3M shares of Rapport Therapeutics, Inc. worth $1.69B — about 105.4% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
169
13F holders
$1.69B
value, 2026 filers
105.4%
of shares outstanding (50.3M sh)
33
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of RAPP's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 7.2M | $241.8M | 0.0% | 15.1% | +0.3% |
| 2 | TRV GP V, LLC | 6.3M | $211.0M | 44.4% | 13.1% | 0.0% |
| 3 | ARCH Venture Management, LLC | 3.7M | $125.3M | 7.8% | 7.8% | 0.0% |
| 4 | GOLDMAN SACHS GROUP INC | 3.0M | $99.9M | 0.0% | 6.2% | +2.2% |
| 5 | BlackRock, Inc. | 2.9M | $96.8M | 0.0% | 6% | +6.7% |
| 6 | Capital International Investors | 2.7M | $89.2M | 0.0% | 5.6% | -9.2% |
| 7 | Cormorant Asset Management, LP | 2.5M | $82.6M | 5.5% | 5.1% | -7.5% |
| 8 | Sofinnova Investments, Inc. | 1.9M | $64.0M | 2.8% | 4% | 0.0% |
| 9 | JOHNSON & JOHNSON | 1.8M | $60.0M | 7.9% | 3.7% | 0.0% |
| 10 | Polar Capital Holdings Plc | 1.6M | $53.9M | 0.1% | 3.4% | -0.3% |
| 11 | VANGUARD CAPITAL MANAGEMENT LLC | 1.6M | $53.1M | 0.0% | 3.3% | +17.3% |
| 12 | BAKER BROS. ADVISORS LP | 1.5M | $52.0M | 0.2% | 3.2% | 0.0% |
| 13 | TRV GP VI, LLC | 969,218 | $32.6M | 13.4% | 2% | 0.0% |
| 14 | STATE STREET CORP | 916,471 | $30.8M | 0.0% | 1.9% | +11.9% |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 869,740 | $29.2M | 0.0% | 1.8% | +9.6% |
| 16 | PERCEPTIVE ADVISORS LLC | 724,342 | $24.3M | 0.4% | 1.5% | -6.3% |
| 17 | PRICE T ROWE ASSOCIATES INC /MD/ | 642,444 | $21.6M | 0.0% | 1.3% | -18.4% |
| 18 | Siren, L.L.C. | 641,469 | $21.6M | 0.5% | 1.3% | 0.0% |
| 19 | ALLIANCEBERNSTEIN L.P. | 629,508 | $21.2M | 0.0% | 1.3% | -9.2% |
| 20 | Capital World Investors | 551,657 | $18.5M | 0.0% | 1.2% | 0.0% |
| 21 | Artisan Partners Limited PartnershipNEW | 437,608 | $14.7M | 0.0% | 0.9% | new |
| 22 | DIMENSIONAL FUND ADVISORS LP | 403,205 | $13.5M | 0.0% | 0.8% | +11.3% |
| 23 | VANGUARD PORTFOLIO MANAGEMENT LLC | 362,611 | $12.2M | 0.0% | 0.8% | +0.7% |
| 24 | Candriam S.C.A. | 346,696 | $11.7M | 0.1% | 0.7% | -0.3% |
| 25 | ALGERT GLOBAL LLC | 303,720 | $10.2M | 0.1% | 0.6% | +35.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.